CSI Pharmacy

Hospitals and Health Care • Nash, Texas, United States • 201-500 Employees

Company overview

Headquarters	459 E New Boston Rd, Nash, Texas 75569, US
Phone number	+15136371246
Website	csipharmacy.com
NAICS	62
SIC	591
Keywords	Patient Advocacy, Home Infusion, Specialty Pharmacy, Ivig And Scig, Rare Disease Therapy
Employees	201-500
Socials

Emails Format About Revenue Employees Insights Funding Tech Stack Trending Companies FAQ

CSI Pharmacy Email Formats

CSI Pharmacy uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@csipharmacy.com), used 66.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@csipharmacy.com	66.5%
{first initial}.{last name}	j.doe@csipharmacy.com	31.8%
{first name}	john@csipharmacy.com	1.7%

About CSI Pharmacy

At Clinical Specialty Infusions (CSI Pharmacy), we are committed to making sure every patient receives the care she or he needs, whether or not you are our client. CSI Pharmacy provides infusion therapy in the home. Over the past few years, CSI Pharmacy has grown from a small, hometown pharmacy into a thriving nationwide specialty pharmacy with two physical locations and plans for more. Our team of expert clinicians, passionate advocates, committed healthcare partners, and strategic reimbursement experts works to develop relationships with individuals who live with rare, debilitating diseases. Patient communities include those with chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, myasthenia gravis, myositis, pemphigus/pemphigoid, Huntington’s disease, primary immune deficiency diseases, and others who require immune globulin therapy and other highly specialized treatments. The people we serve are so much more than patients; they are members of our family.

CSI Pharmacy revenue & valuation

Annual revenue	$20,000,000
Revenue per employee	$71,000
Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues	$64,000,000
Total funding	No funding